Returned drugs headache for wholesalers

Published: 2006-07-19 06:57:00

Updated: 2006-07-19 06:57:00

Drug wholesalers have found it increasingly difficult to deal with expired medicine stocks as well as product license-retracted ones due to the controversial bioequivalence data fabrication.

Pharmaceutical business sources said drug wholesalers just wait for decisions from pharmaceutical compa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK